Discover 1,972 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,972
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
for
Systemic Lupus Erythematosus (SLE),
Location: Cooper City FL, Miami FL, Tamarac FL, Tampa FL,
Sponsor: EMD Serono Research & Development Institute, Inc.
A Phase 1 Study of 177Lu-IM-3050 in Participants With Advanced Cancer
for
Solid Malignancies
Location: Miami FL, Dothan AL, Houston TX, Palo Alto CA
Sponsor: Immunome, Inc.
Sex: All
Age: 18+
Code: NCT07505771
Phase 1, Recruiting
Targeted Pediatric High-Grade Glioma Therapy
for
High Grade Glioma, Diffuse Intrinsic Pontine Glioma,
Location: Miami FL, Durham NC, Washington D.C. DC, Cincinnati OH,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 1 - 39
Code: NCT05839379
Recruiting
SmartRisk Stroke Prediction by MRI of Carotid Disease
for
Atherosclerotic Disease, Carotid
Location: Miami FL, Morgantown WV, Houston TX, New York NY,
Sponsor: VPDiagnostics
Sex: All
Age: 18+
Code: NCT00860184
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
for
Lung Transplant; Complications,
Location: Miami FL, Durham NC, Nashville TN, Falls Church VA,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06399302
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Miami FL, Port Charlotte FL, Rockledge FL, Maitland FL,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase 2, Recruiting
FAMILY Sleep Program
for
Cancer
Location: Coral Gables FL
Sponsor: University of Miami
Sex: All
Age: 18+
Code: NCT06571305
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy